Tolerance.ca
Directeur / Éditeur: Victor Teboul, Ph.D.
Regard sur nous et ouverture sur le monde
Indépendant et neutre par rapport à toute orientation politique ou religieuse, Tolerance.ca® vise à promouvoir les grands principes démocratiques sur lesquels repose la tolérance.

AstraZeneca COVID-19 vaccine FAQ: Why do the age recommendations keep changing? Does it cause VIPIT blood clots? Is it effective against variants?

(Version anglaise seulement)
par Dr. Alexander Wong, Associate Professor, Infectious Diseases, University of Saskatchewan
Partagez cet article
Many people have questions about the changing guidelines for the use of AstraZeneca’s COVID-19 vaccine. Here are some answers from infectious disease specialist Dr. Alexander Wong.

How is the AstraZeneca vaccine different from the other COVID-19 vaccines?


ChADOx1 nCoV-19/AZD1222 (AstraZeneca’s COVID-19 vaccine, also called the Oxford-AstraZeneca vaccine and COVISHIELD) uses a modified adenovirus “vector” to deliver the genetic code for the SARS-CoV-2 spike…


Lire l'article complet

© La Conversation -


Suivez-nous sur ...
Facebook Twitter